@FierceMedDev: France's Labco tiptoes closer to IPO. FierceDiagnostics article | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceDiagnostics: Alere earns FDA clearance for rapid diagnostic of Strep A. News | Follow @VarunSaxena2
@EmilyWFierce: Roche nabs EU approval for Avastin for cervical cancer. Report from FiercePharma | Follow @EmilyWFierce
> Hospira ($HSP) was slapped with an FDA warning letter for problems at a facility in Italy. Story
> Researchers at Purdue University are developing self-assembling, bioinstructive collagen materials that can be used to create customized 3-D tissue and organs outside the body for research, drug discovery and testing. More
> The FDA is expanding its Experiential Learning Program, which focuses on manufacturing for medical technologies, to 34 new areas including continuous glucose monitors, insulin pumps, mass spectrometry and assay development. Article
> German medical device firm B. Braun has spawned 8 billionaires since founding in 1839, Forbes reports. Story
> India is planning to roll out its first medical devices industrial parks in Gujarat and Tamil Nadu. Article
Biotech News
@FierceBiotech: One of Shire's top blockbuster drug prospects flops in a key PhII study. News | Follow @FierceBiotech
@JohnCFierce: What bubble? Woodford boosts biotech fund max to $1.2B as investors crowd in. More | Follow @JohnCFierce
@DamianFierce: ICYMI: The thrilling conclusion to #FierceMadness and why I've had "One Shining Moment" stuck in my head all day. Story | Follow @DamianFierce
> Edge Therapeutics hauls in $72.5M for brain injury R&D. More
> Prothena files for follow-on offering to build $400M R&D war chest. News
Pharma News
@FiercePharma: AZ's Onglyza has most to lose at FDA safety confab, analysts say. Story | Follow @FiercePharma
@EricPFierce: Supply chain slip results in expired #Pfizer birth control pills being sold in Canada. More | Follow @EricPFierce
@CarlyHFierce: Mid-cap biotech beats most of the big dogs with 21.9% revenue growth. Article | Follow @CarlyHFierce
> Natco brings its scrappy style to U.S. with Copaxone, Revlimid knockoffs. News
> Vermont governor demands price cut for Amphastar's overdose antidote. Story
CRO News
> WuXi gets a manufacturing subsidiary on the Chinese stock market. Report
> Parexel partners up for clinical trial education. News
> Catalent reaches into Australia with latest buyout. More
> PPD sets off in Japan with SNBL joint venture. Story
> AMRI shutters another plant with an eye on its bottom line. Article
Vaccines News
> GSK relocates vaccine R&D to Maryland with new global center. Story
> Sanofi teams up with VBI Vaccines to improve vaccine stability. News
> Duke University scores $20M from NIH to develop HIV vaccine. Report
> Sanofi 'flipping the model' for high-stakes dengue rollout. More
> Northwest Bio gets $40M more for controversial brain cancer vaccine. Article
Pharma Manufacturing News
> Report: Supply chain efficiency can boost both top- and bottom-line results. Story
> Cipla buying Brazilian distributor for beachhead there. News
> Expired Pfizer contraceptives recalled after supply chain fumble. Report
> Indonesia market expanding but local producers can't keep up. Article
> Chinese drugmaker to build $60M API plant. Story
Pharma Asia News
> Japan, S. Korea hospitals ink clinical pact on regenerative medicine. News
> China's Sihuan marks first U.S. patient enrollment of PhI oncology candidate. Item
> India drug price chief sacked as essential drug prices rise. Article
> U.S. unit of Glenmark settles Medicaid charges for $25M. Story
> Asian device market set to leap to $15B in 2017. Report